Heritage Global Partners, in partnership with Surplus Solutions, is selling late model biotechnology equipment surplus to the ongoing operations of Celularity.
Clinical and commercial stage biotechnology company Celularity develops off-the-shelf allogeneic cell therapies derived from placenta and used in the treatment of cancer, infectious, immunologic and degenerative diseases.
The online auction will take place between the 17th and 19th of July. Lots featured in the sale include: (2) Sartorius Stedim BIOSTAT STR 50L cell cultivation system, Cytivia AKTA Avant 150 chromatography system, (20+) Cytivia/GE Xuri cell expansion system W25, Cytek Aurora flow cytometer, (2) Miltenyi CliniMACS Plus cell separation system, Li-Cor Odyssey CLx imaging system, Beckman Coulter Multisizer 4e Coulter cell analyzer, (6) Fresenius Kabi LOVO cell processing system, (2) Acea xCELLigence single-plate real time cell analyzer, (2) Beckman Coulter Vi-Cell XR cell viability analyzer, (15) Terumo sterile tubing welder, (20+) New Brunswick Innova 2300 shaker, Zeiss Axiovert 40CFL microscope, Applied Biosciences QuantStudio Absolute Q, Thermo Fisher Nanodrop 2000, Tuttnauer electronic laboratory autoclave, Life Technologies QuantStudio AccuFill, (50+) biosafety cabinets and more. The assets are located in Florham Park, New Jersey and can be viewed by appointment only.
Headquartered in San Diego, California Heritage Global Partners is a full-service auctioneering company managing sales at all scales – from single assets through to complete turnkey facilities and factories. Heritage Global Partners works with clients across 28 different manufacturing, financial and technology industries, including the electronics, pharmaceutical, energy and food and beverage sectors.
For further information about this, or any other Heritage Global Partners auction, please visit:
